Added to YB: 2025-05-08
Pitch date: 2025-05-06
CVSG.L [neutral]
CVS Group plc
+0.16%
current return
Author Info
Asymmetric Ventures Portfolio is a CFA and investor looking for asymmetric investments in Europe and North America. Sign up for the newsletter.
Company Info
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
Market Cap
GBP 931.2M
Pitch Price
GBP 12.82
Price Target
N/A
Dividend
0.62%
Sector
Health Care Providers and Services
Category
special_situation
CVS Group and the CMA Remedies: A Turning Point for Valuation Recovery?
CVSG.L (update): UK vet chain +10-15% on mild CMA remedies: no practice sales, pricing transparency, medicine caps (~30% of EBITDA). Sold crematoria biz (£42.4M, 10x EBITDA). Trading at just 6-7x EBITDA vs PE-backed peers >10x. Australia expansion promising. Final decision Nov 2025, but worst case avoided.
Read full article (8 min)